The Spanish Version of the Edmonton Symptom Assessment System-Revised (ESAS-r): First Psychometric Analysis Involving Patients With Advanced Cancer
The Spanish Version of the Edmonton Symptom Assessment System-Revised (ESAS-r): First Psychometric Analysis Involving Patients With Advanced Cancer
复制标题
DOI：
10.1016/j.jpainsymman.2012.01.014
复制
发表时间：
2013-01-01
影响因子：
4.7
通讯作者：
Centeno, Carlos
中科院分区：
文献类型：
--
作者：
Carvajal, Ana;Hribernik, Nezka;Centeno, Carlos
上下文埃德蒙顿症状评估系统（ESAS）是一种广泛用于晚期癌症患者症状评估的姑息治疗措施。该工具已通过包括西班牙文在内的不同语文的验证。Watanabe等人于2010年开发了修订版（ESAS-r）。开发ESAS-r的西班牙语版本，并检查其心理测量学特性。基于最初的英文版本，一组专家创建了ESAS-r的西班牙语版本，并将其用于一组晚期癌症患者。患者完成了ESAS和ESAS-r，并询问了他们对该工具的看法。ESAS-r的心理测量学特性进行了分析的等效性，内部一致性和判别效度。来自西班牙和危地马拉的66名患者参加了调查。患者认为ESAS-r比ESAS更容易理解和完成。值得注意的是，患者更喜欢ESAS-r（47%）而不是ESAS（15%; P <0.0007）。至于信度，我们发现良好的内部一致性（克朗巴赫的α 0.86），和两个版本的等效性是0.71和0.94之间。ESAS-r区分了住院患者和门诊患者（Mann-Whitney U检验; P = 0.02）以及具有不同姑息性能状态的患者（疼痛、疲劳、嗜睡、食欲不振、幸福感的斯皮尔曼rho; P <0.01）。ESAS-r是一个有效的工具，具有足够的心理测量学特征。该版本是晚期癌症患者的首选。因此，ESAS-r西班牙文版可以取代ESAS的使用。J Pain Symptom Manage 2013; 45：129 - 136. (C)2013年美国癌症疼痛缓解委员会。爱思唯尔公司出版All rights reserved.
Context. The Edmonton Symptom Assessment System (ESAS) is a measure widely used in palliative care for the assessment of symptoms in patients with advanced cancer. The tool has been validated in different languages, including Spanish. A revised version (ESAS-r) was developed by Watanabe et al. in 2010.Objectives. To develop the Spanish version of the ESAS-r and examine its psychometric properties.Methods. Based on the original English version, a group of experts created a Spanish version of the ESAS-r and administered it to a group of advanced cancer patients. Patients completed the ESAS and ESAS-r and were asked for their perceptions of the tool. The psychometric properties of the ESAS-r that were analyzed were equivalence, internal consistency, and discriminant validity.Results. Sixty-six patients from Spain and Guatemala participated in the survey. Patients perceived the ESAS-r to be significantly easier to understand and easier to complete than the ESAS. Significantly, patients preferred the ESAS-r (47%) to the ESAS (15%; P < 0.0007). As to reliability, we found good internal consistency (Cronbach's alpha 0.86), and the equivalence of the two versions was between 0.71 and 0.94. The ESAS-r discriminates between inpatients and outpatients (Mann-Whitney U test; P = 0.02) and among those with different palliative performance status (Spearman's rho for pain, tiredness, drowsiness, lack of appetite, well-being; P < 0.01).Conclusion. The ESAS-r is a valid instrument with adequate psychometric characteristics. This version is preferred by patients with advanced cancer. The Spanish version of the ESAS-r can, therefore, replace the use of the ESAS. J Pain Symptom Manage 2013;45:129-136. (C) 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.